EP3993873A4 - Mammary tumor virus suppression - Google Patents

Mammary tumor virus suppression Download PDF

Info

Publication number
EP3993873A4
EP3993873A4 EP20834735.1A EP20834735A EP3993873A4 EP 3993873 A4 EP3993873 A4 EP 3993873A4 EP 20834735 A EP20834735 A EP 20834735A EP 3993873 A4 EP3993873 A4 EP 3993873A4
Authority
EP
European Patent Office
Prior art keywords
mammary tumor
tumor virus
virus suppression
suppression
mammary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20834735.1A
Other languages
German (de)
French (fr)
Other versions
EP3993873A1 (en
Inventor
Sophie Bartsich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virago Vax Inc
Original Assignee
Virago Vax Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/460,295 external-priority patent/US20190343938A1/en
Application filed by Virago Vax Inc filed Critical Virago Vax Inc
Publication of EP3993873A1 publication Critical patent/EP3993873A1/en
Publication of EP3993873A4 publication Critical patent/EP3993873A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • A61K2039/812—Breast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/12011—Betaretrovirus, e.g. mouse mammary tumour virus
    • C12N2740/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/12011—Betaretrovirus, e.g. mouse mammary tumour virus
    • C12N2740/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
EP20834735.1A 2019-07-02 2020-07-02 Mammary tumor virus suppression Pending EP3993873A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16/460,295 US20190343938A1 (en) 2019-07-02 2019-07-02 Mammary tumor virus vaccine
US201962934858P 2019-11-13 2019-11-13
PCT/US2020/040742 WO2021003421A1 (en) 2019-07-02 2020-07-02 Mammary tumor virus suppression

Publications (2)

Publication Number Publication Date
EP3993873A1 EP3993873A1 (en) 2022-05-11
EP3993873A4 true EP3993873A4 (en) 2023-09-20

Family

ID=74100827

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20834735.1A Pending EP3993873A4 (en) 2019-07-02 2020-07-02 Mammary tumor virus suppression

Country Status (3)

Country Link
EP (1) EP3993873A4 (en)
CA (1) CA3145293A1 (en)
WO (1) WO2021003421A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090081220A1 (en) * 2004-01-29 2009-03-26 Jacob Hochman Method for diagnosing and treatment of breast cancer and pharmaceuticals composition and kit for same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU745773B2 (en) * 1998-04-08 2002-03-28 International Bioimmune Systems, Inc. Immunomodulatory compositions of MMTV antigens and methods of using same
WO2005072748A1 (en) * 2004-01-21 2005-08-11 Gilead Sciences, Inc. Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis
US20120135950A1 (en) * 2009-05-21 2012-05-31 The Regents Of The University Of Michigan Antiviral treatment of lymphoma and cancer
US9383367B1 (en) * 2010-12-07 2016-07-05 Chunli Liu Methods of detecting conjugation site-specific and hidden epitope/antigen
CA3054135A1 (en) * 2016-02-22 2017-08-31 Brigham Young University Method and compositions for the treatment of anemia through the inhibition of furin
US20190343938A1 (en) * 2019-07-02 2019-11-14 Virago Vax Inc. Mammary tumor virus vaccine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090081220A1 (en) * 2004-01-29 2009-03-26 Jacob Hochman Method for diagnosing and treatment of breast cancer and pharmaceuticals composition and kit for same

Also Published As

Publication number Publication date
EP3993873A1 (en) 2022-05-11
CA3145293A1 (en) 2021-01-07
WO2021003421A1 (en) 2021-01-07

Similar Documents

Publication Publication Date Title
EP3577132A4 (en) Oncolytic virus therapy
EP3910244A4 (en) Cooker
EP3957576A4 (en) Film-packed tissue set package
EP3824896A4 (en) Virus inactivating agent
EP3919072A4 (en) Cancer vaccine preparation
EP3656854A4 (en) Virus for treating tumors
EP3996744A4 (en) Viral vector therapy
EP3962524A4 (en) Cancer treatment
EP3878374A4 (en) Occluder
EP3634478A4 (en) Methods of suppressing microglial activation
EP4029418A4 (en) Cooker
EP3976100A4 (en) Combination therapy
EP3942974A4 (en) Cooker
EP3866847A4 (en) Virus vaccine
EP3993873A4 (en) Mammary tumor virus suppression
EP4017962A4 (en) Bio-printed kidney tissue
EP4031922A4 (en) Virtual fiducials
EP3775292A4 (en) Virus bioresistors
EP4028941A4 (en) Visitor-tailored property configuration
EP3942061A4 (en) Tumor-selective combination therapy
EP3947742A4 (en) Stratification of risk of virus associated cancers
EP3883968A4 (en) Modified fc region
EP3797713A4 (en) Ligator
AU2019903260A0 (en) Cancer vaccine
EP3939607A4 (en) Dengue virus vaccine

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220131

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20230818

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 39/21 20060101ALI20230811BHEP

Ipc: A61P 31/12 20060101ALI20230811BHEP

Ipc: A61P 31/14 20060101AFI20230811BHEP